New combo attack on aggressive sarcomas
NCT ID NCT04037527
Summary
This early-stage study tested the safety of combining two chemotherapy drugs (gemcitabine and docetaxel) with radiation before surgery for adults with large, high-grade soft tissue sarcomas in their arms or legs. The main goal was to find the highest dose patients could tolerate without severe side effects. Researchers also wanted to see how this treatment affected the patient's immune system.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.